Evidence map›Paper›PMID 33806689›Full record

ArticleNutrients2021

Self-Reported DHA Supplementation during Pregnancy and Its Association with Obesity or Gestational Diabetes in Relation to DHA Concentration in Cord and Maternal Plasma: Results from NELA, a Prospective Mother-Offspring Cohort.

Antonio Gázquez, María J Giménez-Bañón, María T Prieto-Sánchez, Carmen Martínez-Graciá, Clara Suárez, Marina Santaella-Pascual, Lina Galdo-Castiñeira, Carmen Ballesteros-Meseguer, Jesús Vioque, Miriam Martínez-Villanueva and 6 more

Open access · goldAbstract readEvaluation Study
In one paragraph

Article in Nutrients, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. DHA supplementation and pregnancy complications.Journal of translational medicine · 2023
    Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 1 country.

Antonio GázquezBiomedical Research Institute of Murcia (IMIB-Arrixaca), 30120 Murcia, Spain.ORCID 0000-0001-5023-7442
María J Giménez-BañónBiomedical Research Institute of Murcia (IMIB-Arrixaca), 30120 Murcia, Spain.
María T Prieto-SánchezBiomedical Research Institute of Murcia (IMIB-Arrixaca), 30120 Murcia, Spain.ORCID 0000-0003-2800-8883
Carmen Martínez-GraciáBiomedical Research Institute of Murcia (IMIB-Arrixaca), 30120 Murcia, Spain.
Clara SuárezBiomedical Research Institute of Murcia (IMIB-Arrixaca), 30120 Murcia, Spain.
Marina Santaella-PascualBiomedical Research Institute of Murcia (IMIB-Arrixaca), 30120 Murcia, Spain.
Lina Galdo-CastiñeiraObstetrics & Gynaecology Service, "Virgen de la Arrixaca" University Clinical Hospital, University of Murcia, 30120 Murcia, Spain.
Carmen Ballesteros-MeseguerObstetrics & Gynaecology Service, "Virgen de la Arrixaca" University Clinical Hospital, University of Murcia, 30120 Murcia, Spain.
Jesús VioqueHealth and Biomedical Research Institute of Alicante (ISABIAL-UMH), 46020 Alicante, Spain.ORCID 0000-0002-2284-148X
Miriam Martínez-VillanuevaBiomedical Research Institute of Murcia (IMIB-Arrixaca), 30120 Murcia, Spain.
Francisco Avilés-PlazaBiomedical Research Institute of Murcia (IMIB-Arrixaca), 30120 Murcia, Spain.
José A Noguera-VelascoBiomedical Research Institute of Murcia (IMIB-Arrixaca), 30120 Murcia, Spain.
Eva MoralesBiomedical Research Institute of Murcia (IMIB-Arrixaca), 30120 Murcia, Spain.
Luís García-MarcosBiomedical Research Institute of Murcia (IMIB-Arrixaca), 30120 Murcia, Spain.
Elvira LarquéBiomedical Research Institute of Murcia (IMIB-Arrixaca), 30120 Murcia, Spain.
On Behalf Of The Nela Study Group
Instituto Murciano de Investigación Biosanitaria · ESUniversidad de Murcia · ESCentro de Investigación Biomédica en Red de Epidemiología y Salud Pública · ES

Funding

ARADyAL network RD160006Fondos FEDER PI16/00422, PI19/00863Instituto de Salud Carlos III CP14/00046Maternal and Child Health and Development Research Network RED SAMID III, RD 16/0022/0009Séneca Foundation 19899/GERM/15Spanish Ministry of Science, Innovation and Universities PIE15/00051
6 · The paper itself

Abstract

Maternal supplementation of docosahexaenoic acid (DHA) during pregnancy has been recommended due to its role in infant development, but its effect on materno-fetal DHA status is not well established. We evaluated the associations between DHA supplementation in pregnant women with obesity or gestational diabetes mellitus (GDM) and maternal and neonatal DHA status. Serum fatty acids (FA) were analyzed in 641 pregnant women (24 weeks of gestation) and in 345 venous and 166 arterial cord blood samples of participants of the NELA cohort. Obese women (

Indexed as

Dietary SupplementsAdultBody Mass IndexDiabetes, GestationalDocosahexaenoic AcidsFatty AcidsFemaleFetal BloodHumansInfant, NewbornMaleMaternal Nutritional Physiological PhenomenaObesityPregnancyPregnancy ComplicationsProspective StudiesDocosahexaenoic AcidsFatty Acidsdiabetesdocosahexaenoic acidfatty acidsobesitypregnancysupplementation

Identifiers

PMID33806689
PMCPMC8000695
OpenAlexW3134965847

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.